0.62
                                            Intensity Therapeutics Inc Aktie (INTS) Neueste Nachrichten
How supply chain issues affect Intensity Therapeutics Inc. stock2025 Market Sentiment & Smart Investment Allocation Tips - newser.com
Ranking Intensity Therapeutics Inc. among high performing stocks via toolsQuarterly Trade Report & Daily Oversold Stock Bounce Ideas - newser.com
Using Bollinger Bands to evaluate Intensity Therapeutics Inc.July 2025 Momentum & Risk Managed Investment Entry Signals - newser.com
Will Intensity Therapeutics Inc. stock benefit from AI adoption2025 Trading Recap & Verified Swing Trading Watchlists - newser.com
Will Intensity Therapeutics Inc. rebound enough to break even2025 Key Highlights & Risk Controlled Stock Alerts - newser.com
How Intensity Therapeutics Inc. stock trades before earnings2025 Retail Activity & Risk Managed Investment Signals - newser.com
Will Intensity Therapeutics Inc. stock reach all time highs in 2025July 2025 Reactions & Fast Exit/Entry Strategy Plans - newser.com
Why Intensity Therapeutics Inc. stock is favored by top institutions2025 Major Catalysts & Capital Protection Trading Alerts - newser.com
How to track smart money flows in Intensity Therapeutics Inc.Weekly Trend Summary & Expert Verified Stock Movement Alerts - newser.com
How interest rate cuts could boost Intensity Therapeutics Inc. stockIndex Update & Community Shared Stock Ideas - newser.com
Will a bounce in Intensity Therapeutics Inc. offer an exitTake Profit & Growth Oriented Trade Recommendations - newser.com
Does Intensity Therapeutics Inc. show high probability of rebound2025 Key Highlights & Precise Buy Zone Tips - newser.com
How Intensity Therapeutics Inc. stock performs in stagflationJuly 2025 Review & Low Drawdown Trading Strategies - newser.com
Intensity Therapeutics surges 395% on phase 1/2 data for solid tumors asset - MSN
Intensity Therapeutics Stock Price, Quotes and Forecasts - Benzinga
Intensity Therapeutics Enters Securities Purchase Agreement - TipRanks
INTS to raise $4.0M via 5,000,000-share registered direct sale - Stock Titan
Intensity Therapeutics prices $4 million registered direct offering By Investing.com - Investing.com South Africa
Intensity Therapeutics announces pricing of $4M registered direct offering of common stock - MSN
Intensity Therapeutics Prices $4 Million Direct Offering - MarketScreener
Intensity Therapeutics prices 5M shares at 80c in registered direct offering - TipRanks
Intensity Therapeutics shares plunge 30% after $4 million discounted stock offering - MSN
Intensity Therapeutics, Inc. (INTS) stock tumbles 30% as $4M direct offering sparks investor concern - parameter.io
Unexpected Surge: Analyzing INTS Performance - timothysykes.com
Intensity Therapeutics prices $4 million registered direct offering - Investing.com
INTS Stock Price and Chart — NASDAQ:INTS - TradingView
Biotech Bombshell: Intensity Therapeutics (INTS) Surges Nearly 400% on Major Cancer Trial News - ts2.tech
Intensity Therapeutics stock tumbles after pricing $4 million offering By Investing.com - Investing.com Nigeria
Intensity Therapeutics stock tumbles after pricing $4 million offering - Investing.com
Intensity Therapeutics stock up nearly 400% on solid tumour data - Yahoo Finance
Intensity Therapeutics (Nasdaq: INTS) prices $4M registered direct, selling 5M shares - Stock Titan
Is Intensity Therapeutics Inc. stock oversold or undervaluedJuly 2025 Reactions & Consistent Income Trade Recommendations - newser.com
Trending tickers: Apple, Amazon, Netflix, Reddit and Intensity Therapeutics - Yahoo! Finance UK
Volume spikes in Intensity Therapeutics Inc. stock – what they meanMarket Sentiment Review & Technical Entry and Exit Alerts - newser.com
How to integrate Intensity Therapeutics Inc. into portfolio analysis toolsEarnings Miss & Verified Trade Idea Suggestions - newser.com
Intensity Therapeutics Stock Cools After-Hours Following 395% Surge: What You Should Know - inkl
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):